8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Jul 29, 2025 · 11mo ago · Accession 0001558370-25-009739
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Aclaris Therapeutics, Inc.
- Ticker
- ACRS
- CIK
- 1557746
- Form type
- 8-K
- Filing date
- Jul 29, 2025
- Report date
- Jul 29, 2025
- Document
- acrs-20250729x8k.htm
- Size
- 4.8 MB